The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
News|Articles|November 22, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 22, 2021
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the
How many people in the US have been vaccinated against COVID-19?
According to the CDC as of today, November 12, 2021, at 3:25 PM, EDT:
• 69.5% of total US population has received at least 1 dose
• 59.2% of total US population is fully vaccinated
• 59.2% of total US population is fully vaccinated
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 74.4%
2. Vermont: 72.6%
3. Rhode Island:72.1%
4. Maine: 71.9%
5. Connecticut: 71.7%
2. Vermont: 72.6%
3. Rhode Island:72.1%
4. Maine: 71.9%
5. Connecticut: 71.7%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, November 22, 2021 at 2:22 PM, EDT, there have been:
• 47 803 194 confirmed cases and
• 771 679 deaths
• 771 679 deaths
The 5 states with the highest total confirmed cases are:
1. California: 5 048 730
2. Texas: 4 308 230
3. Florida: 3 721 503
4. New York: 2 674 200
5. Illinois: 1 775 259
2. Texas: 4 308 230
3. Florida: 3 721 503
4. New York: 2 674 200
5. Illinois: 1 775 259
Deaths: California has the highest number of deaths due to COVID-19 with 73 843 reported fatalities, followed by Texas with 73 390 and Florida with 61 081.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 257 940 222 confirmed cases, 5 155 664 deaths, and 7 420 871 256 vaccine doses administered.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement